Basic info
Industry
biotechnology research
Sectors
Biotechnology
virology
Life Science
Covid-19 vaccine
cell-based manufacture
Medical Device
Influenza vaccine
Universal influenza vaccine
Date founded
2006
Funding rounds raised
Total raised
$23M
from 2 investors over 2 rounds
V
Vivaldi Biosciences Inc. raised $23M on January 21, 2009
Investors: Bay City Capital
V
Vivaldi Biosciences Inc. raised $2M on May 18, 2007
Investors: Bay City Capital